Literature DB >> 15199549

Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer.

Carsten Harms1, Salama A Salama, Carlos H Sierra-Torres, Nohelia Cajas-Salazar, William W Au.   

Abstract

We have previously investigated the role of polymorphic chemical metabolizing genes in the susceptibility to the development of lung cancer using 110 primary lung cancer patients and 119 matched smoker controls. Together with data from the present study on DNA repair genes, we did not observe significant associations between any single variant genotype for several DNA-repair and chemical-metabolizing genes (XPD [or ERCC2], XRCC1, XRCC3, GSTM1, GSTT1, MPO, and mEH [or EPHX1]) and lung cancer. In the present study, we have further evaluated a nested group of 79 patients and 69 matched controls, and observed that increased chromosome aberrations (CAs) were associated with variant DNA-repair genotypes among both the patient and the control groups, with a significant increase for individuals having the XPD Lys/Gln + Gln/Gln genotypes (P = 0.046). Patients often had significantly increased CAs compared with controls with the same DNA-repair genotype and with similar cigarette smoking habits (< or =40 pack-years or >40 pack-years). Analyses of interactions between the DNA-repair and chemical-metabolizing genes indicated that the most significant interactions were between the repair genotypes and the GSTM1/T1 null genotypes. Significant increases in CA from the interactions were often observed among patients with < or =40 pack-years, but not among those with >40 pack-years. Since some variant DNA-repair genotypes have functional deficits for DNA repair, the association between variant DNA-repair genotypes and increased CAs suggests a risk mechanism for the development of lung cancer, with the DNA-repair genotypes interacting with variant chemical metabolizing genotypes to further increase the risk. The observation that patients had significantly increased CA frequencies compared with controls, irrespective of genotype, suggests that patients have additional factors that contribute to the development of lung cancer. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199549     DOI: 10.1002/em.20031

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  37 in total

1.  Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines.

Authors:  Scott M Langevin; John P A Ioannidis; Paolo Vineis; Emanuela Taioli
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

2.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Wenlong Zhai; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-04-03

3.  No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis.

Authors:  Yun-Hua Xu; Lin-Ping Gu; Ying-Jia Sun; Bai-Jun Cheng; Shun Lu
Journal:  Tumour Biol       Date:  2013-01-09

4.  EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Hong Liu; Hai-Yan Li; Hong-Jie Chen; Yong-Jie Huang; Shao Zhang; Jing Wang
Journal:  Tumour Biol       Date:  2012-10-09

Review 5.  Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.

Authors:  Siwen Wang; Jie Zhu; Ruxin Zhang; Siyang Wang; Zongheng Gu
Journal:  Tumour Biol       Date:  2013-02-03

6.  DNA Repair Gene Polymorphisms in the Nucleotide Excision Repair Pathway and Lung Cancer Risk: A Meta-analysis.

Authors:  Chao-Rong Mei; Meng Luo; Hong-Mei Li; Wen-Jun Deng; Qing-Hua Zhou
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

7.  Comprehensive assessment of the association between XPD rs13181 polymorphism and lung cancer risk.

Authors:  Hai-Ying Wu; Ling-Yu Ding
Journal:  Tumour Biol       Date:  2014-05-21

8.  The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case-control studies.

Authors:  Zhiyong Zhao; Chuan Liu; Yong Zeng; Lei Gu; Mingzhen Ying; Ning Wang; Bin Hao; Huiyan Yao; Changqing Su; Yajie Wang; Yuchen Ma
Journal:  Tumour Biol       Date:  2014-01-14

9.  Lack of association between XRCC3 rs861539 (C > T) polymorphism and lung cancer risks: an update meta-analysis.

Authors:  Chun-Lei Shi; Rong Li; Li-Wen Xiong; Ai-Qin Gu; Bao-Hui Han; Wei Gu
Journal:  Tumour Biol       Date:  2013-03-26

10.  Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis.

Authors:  Chikako Kiyohara; Koichi Takayama; Yoichi Nakanishi
Journal:  J Nucleic Acids       Date:  2010-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.